Schizophrenia and related disorders during mid- to late-life (R01)
Funds work on how schizophrenia emerges and changes after 35 — the age group where most patients are and least research has gone.
Most people living with schizophrenia are over 35 — some diagnosed decades ago and ageing with the illness, some diagnosed late. Almost all the research attention has gone to first-episode psychosis in young adults, and the result is that the mechanisms driving the illness in mid and late life are, in NIH's own words, poorly understood.
This notice funds translational work on that gap — two conne…
Translational research into how schizophrenia and related disorders emerge and change during mid to late life, in both people diagnosed young and ageing with the illness and people first diagnosed later, and into the targets that work suggests for future prevention and treatment.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
More from NIH
All grants from this funder →GREGoRi Data Coordination and Outreach Center
🇺🇸NIH · United States
Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.
GREGoRi Innovation Projects
NIH · United States
Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.
GREGoRi Technology Integration Center
🇺🇸NIH · United States
Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases
🇺🇸NIH · United States
Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)
🇺🇸NIH · United States
Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01)
NIH · United States
Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.
Similar grants
Browse the directory →
Mission Soil and Cancer: Living Labs for Carcinogenic Contamination
🇪🇺European Commission · European Union
Funds two €12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.
Independent Living and Inclusion for Persons with Disabilities
🇪🇺European Commission · European Union
Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.
Michigan Translational Research And Commercialization
🇺🇸MEDC · United States
Funds Michigan translation projects moving university research toward commercialization through innovation hubs.
The Genesis Mission: Transforming Science and Energy with AI
🇺🇸DOE SC · United States
Supports AI for science progress from early concept stages toward national-scale implementation.
FFG Austrian Life Sciences
🇦🇹FFG · Austria
Supports Austrian life-science innovation in digital health, drug development, and medical technologies.
Life Sciences Transformational R&D Investment Fund (TRIF) Pilot
🇬🇧DSIT · United Kingdom
Capital grants for large-scale UK life sciences R&D investments.